Healthcare: 3 Tough Luck Tumbles – Are They Buys?
Industry Focus - Een podcast door The Motley Fool
Categorieën:
Spark Therapeutics, Rite Aid, and Alnylam shares have tumbled following news, but that doesn’t necessarily make all three stocks worth buying. Stocks: ONCE, RAD, ALNY
